 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease |
| Sun-Gi Kim, Byung-Kwon Kim, Kyumin Kim, Sungsoon Fang |
|
Endocrinol Metab. 2016;31(4):500-504. Published online December 20, 2016 DOI: https://doi.org/10.3803/EnM.2016.31.4.500 |
|
Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease Endocrinology and Metabolism. 2016;31(4):500  Non-Alcoholic Fatty Liver Disease: The Bile Acid-Activated Farnesoid X Receptor as an Emerging Treatment Target Journal of Lipids. 2012;2012:1-8 Implications for Farnesoid X Receptor Signaling on Bile Acid Metabolism as a Potential Therapeutic Strategy for Nonalcoholic Fatty Liver Disease The Korean Journal of Obesity. 2016;25(4):167-175 Bile Acid Receptor Farnesoid X Receptor: A Novel Therapeutic Target for Metabolic Diseases Journal of Lipid and Atherosclerosis. 2017;6(1):1 Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease Clinical and Translational Gastroenterology. 2018;9(6):e164 Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes Diabetes mellitus. 2018;20(6):449-453 Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease Biomedicine & Pharmacotherapy. 2020;121:109609 Use of Farnesoid X Receptor Agonists to Treat Nonalcoholic Fatty Liver Disease Digestive Diseases. 2015;33(3):426-432 The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: Hype or hope? Hepatology. 2004;40(1):260-263 Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-κB: New insights into hepatic inflammation Hepatology. 2008;48(5):1383-1386 |
